Expand ACAD Menu
ACAD MENU

ACAD Latest Press Releases

-- May 9, 2024 --

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences Business Wire 4:58 PM

-- May 8, 2024 --

Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview Business Wire 4:05 PM

-- April 29, 2024 --

Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship Business Wire 4:16 PM

-- April 24, 2024 --

Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024 Business Wire 4:05 PM

-- April 22, 2024 --

Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada Business Wire 9:04 AM

-- April 19, 2024 --

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- April 17, 2024 --

Acadia Pharmaceuticals Presents New DAYBUE (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting Business Wire 4:05 PM

-- April 2, 2024 --

Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development Business Wire 4:05 PM

-- April 1, 2024 --

Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference Business Wire 4:05 PM

-- March 15, 2024 --

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- March 13, 2024 --

Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day Business Wire 4:05 PM

-- March 11, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD PRNewswire 7:25 PM
Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia Business Wire 4:05 PM

-- March 7, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD Globe Newswire 4:07 PM

-- March 3, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD PRNewswire 10:15 AM

-- February 29, 2024 --

Acadia Pharmaceuticals to Participate in TD Cowen's 44th Annual Health Care Conference on March 6, 2024 Business Wire 9:05 AM

-- February 28, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD Globe Newswire 3:10 PM

-- February 22, 2024 --

ACADIA Pharmaceuticals Inc. Investors: Please contact the Portnoy Law Firm to recover your losses Globe Newswire 8:16 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD Globe Newswire 9:22 AM

-- February 21, 2024 --

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- February 13, 2024 --

Tonix Pharmaceuticals Pioneering in the shifting landscape of the Dynamic CNS Therapeutics Market Globe PR Wire 4:50 AM

-- January 30, 2024 --

Acadia Announces Additions to Executive Team Business Wire 8:48 PM

-- January 19, 2024 --

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- January 18, 2024 --

Acadia Announces the Passing of Former President Srdjan (Serge) Stankovic Business Wire 4:05 PM

-- December 21, 2023 --

Acadia Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 Business Wire 4:05 PM

-- December 18, 2023 --

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM

-- December 13, 2023 --

Delaware District Court Rules in Favor of Acadia on Formulation Patent Construction (Markman) Claims Regarding NUPLAZID (pimavanserin) Business Wire 9:24 PM
Delaware Federal District Court Rules in Favor of Acadia Pharmaceuticals in NUPLAZID (pimavanserin) Patent Litigation Business Wire 1:41 PM